Understanding How Recursion Is Using Ai To Rethink Drug Discovery
If you are looking for information about How Recursion Is Using Ai To Rethink Drug Discovery, you have come to the right place. In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of
Key Takeaways about How Recursion Is Using Ai To Rethink Drug Discovery
- Join Imran Haque, Senior Vice President of
- A new video shares the story of
- Stacie Calad-Thomson, North America business
- Stephen MacKinnon is the VP of Applied ML at
- Presented By: Lina Nilsson, PhD Speaker Biography: Lina Nilsson is Senior Director of Data Science Product at
Detailed Analysis of How Recursion Is Using Ai To Rethink Drug Discovery
Chris Gibson, Cofounder and CEO of Chris Gibson, SEE THE SCIENCE FOR YOURSELF Watch
NVIDIA #BioNeMo, now features more than a dozen #generativeAI models, including
We hope this detailed breakdown of How Recursion Is Using Ai To Rethink Drug Discovery was helpful.
